CAR T-cell Therapy Directed to CD70(St Jude Children's Research Hospital)

N/A

Report date: 2024/04/16 20:00:32

Base Information

Drug NameCAR T-cell Therapy Directed to CD70(St Jude Children's Research Hospital)
Drug Alias NameAutologous CD70-CAR T cell Therapy(St Jude Children's Research Hospital)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacementsCD70 antigen modulators
TargetsCD70 antigen
Therapy Area/IndicationsMyelodysplastic SyndromesHematologic NeoplasmsLymphoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSt. Jude Children'S Research Hospital
China Registration ClassN/A

Develop Information

Active CompaniesSt. Jude Children'S Research Hospital
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesHematologic NeoplasmsLymphoma +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A